A Major Gift for Parkinson’s Research

Portrait

Paul and Jean Amos

Portrait of DeLong

Parkinson’s expert Mahlon DeLong hopes the gift will attract funding for a model Parkinson’s center.

Campaign Emory

campaign.emory.edu

Jean and Paul Amos of Columbus, Georgia, have committed $4 million to name the Jean and Paul Amos Parkinson’s Disease and Movement Disorders Research Program within Emory School of Medicine. The fund will be used to launch innovative research and clinical trials, recruit scientists, and train fellows.

Mahlon DeLong, William Timmie Professor of Neurology and one of the nation’s foremost experts on Parkinson’s and movement disorders, has treated Paul Amos for many years. “The gift from the Amos family will give us the resources to help support ongoing research and to initiate new research programs for Parkinson’s disease,” DeLong says. “In these difficult times, philanthropic support such as this is absolutely vital for research to continue and to further develop Emory’s Parkinson’s disease program. We are most grateful to the Amos family members for their generous support.”

“Dr. DeLong has been wonderful and has been on the forefront of everything regarding research and clinical care,” says Jean Amos. DeLong and his colleagues hope this generous gift will create momentum and help them realize their longtime goal of building a center that will be a model of integrated, patient-centered care. This model is particularly important to patients with Parkinson’s and movement disorders because the complexity of these diseases necessitates numerous visits and care from specialists in a wide variety of areas, including neurology, neurosurgery, psychiatry, gastroenterology, urology, sleep disorders, sleep and swallowing, and physical and occupational therapy.

Emory specialists provide care yearly for around 12,000 patients with Parkinson’s, atypical Parkinson’s, and movement disorders. As the population ages, that number is expected to grow exponentially.

“Thanks to generous and forward-thinking donors like the Amoses, Emory’s Parkinson’s team has and will continue to change life dramatically for many of these patients,” says Stewart Factor, Vance Lanier Chair of Neurology and clinical director of the Movement Disorders Research Program.

“Gifts like the Amoses’ contribution are of great importance in bringing about advances in the early detection, treatment, and possible prevention of Parkinson’s and other movement disorders,” he says.

The gift will help recruit the best researchers in neuroimaging, neurogenetics, and neuropathology, three areas that are key to these advances.

“Research has helped improve Paul’s quality of life over the years, and both of us want to see that research continue and ultimately lead to a cure for Parkinson’s,” Jean Amos says. “We made this gift in hopes that it will benefit others suffering from Parkinson’s and encourage others to give for Parkinson’s research.”

Email the editor